Anticoagulant: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Starting with small content I wrote at Wikipedia) |
imported>Robert Badgett No edit summary |
||
| Line 5: | Line 5: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
==See also== | |||
* [[Anticoagulation]] | |||
[[Category:CZ Live]] [[Category:Health Sciences Workgroup]] | [[Category:CZ Live]] [[Category:Health Sciences Workgroup]] | ||
Revision as of 16:31, 20 July 2007
Vitamin K antagonists
Adverse effects
Patients aged 80 years or more may be especially susceptible to bleeding complications with a rate of 13 bleeds per 100 person-years.[1]
References
- ↑ Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (2007). "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation". Circulation 115 (21): 2689-96. DOI:10.1161/CIRCULATIONAHA.106.653048. PMID 17515465. Research Blogging. PMID 17515465